Emergent Biosolutions, Inc. (EBS) is trading at $4.49 down 1.32% over the past 24 hours. Its Galaxy Score is 56.6, LunarCrush's combined measure of market and social performance. Over the last 24 hours it has seen 2.2K engagements and 23 posts with 86% positive social sentiment.
AI summary: Emergent BioSolutions Inc. (EBS) biodefense vaccine developer tied to PAHPA-funded ACAM2000 contract amid policy timing uncertainty. Contract win supports near-term deliveries, but policy timing uncertainty caps upside and keeps shares near 52-week lows.
Emergent Biosolutions, Inc. (EBS) is tracked on LunarCrush, where you can follow its price alongside live social activity and sentiment across X, Reddit, YouTube and other networks.
Emergent Biosolutions, Inc. (EBS) is trading at $4.49, down 1.32% over the past 24 hours.
$EBS has a Galaxy Score of 56.6 — LunarCrush's 0–100 measure combining an asset's market and social performance.
Yes. $EBS social sentiment is 86% positive across social posts over the last 24 hours.
There have been 23 posts about $EBS over the last 24 hours.
On LunarCrush — follow $EBS's real-time social sentiment, engagement and market activity across X, Reddit, YouTube, TikTok and news in one place.